首页> 外文期刊>Antimicrobial Resistance and Infection Control >Antimicrobial stewardship auditing of patients reviewed by infectious diseases physicians in a tertiary university hospital
【24h】

Antimicrobial stewardship auditing of patients reviewed by infectious diseases physicians in a tertiary university hospital

机译:三级大学医院传染病医师对患者进行抗菌管理审核

获取原文
获取原文并翻译 | 示例
           

摘要

Background The optimal way for antimicrobial stewardship programs (ASPs) to interact with existing infectious disease physician (IDP) services within the same institution is unknown. In our institution, IDPs and our prospective audit and feedback ASP operate independently, with occasionally differing recommendations offered for the same inpatient. We performed a retrospective audit on inpatients that had been reviewed by both IDPs and ASP within a 7-day period, focusing on cases where different therapy-modifying recommendations had been offered. We analyzed the outcomes in inpatients where the ASP recommendations were accepted and compared these with the inpatients where the IDP recommendations were accepted instead. Outcomes assessed were 30-day mortality post-ASP review, unplanned re-admission within 30 days post-discharge from hospital, and clinical deterioration at 7 days post-ASP review.
机译:背景技术抗菌药物管理计划(ASP)与同一机构内现有的传染病医生(IDP)服务进行交互的最佳方法尚不清楚。在我们的机构中​​,国内流离失所者以及我们的预期审计和反馈ASP都是独立运作的,偶尔会为同一名患者提供不同的建议。我们对住院患者进行了回顾性审核,并在7天内对IDP和ASP均进行了审核,重点关注了提出不同治疗修改建议的患者。我们分析了接受ASP建议的住院患者的结局,并将其与接受IDP建议的住院患者进行了比较。评估的结果是ASP复查后30天死亡率,出院后30天内计划外入院以及ASP复查后7天临床恶化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号